灾难性的抗脂抗体综合征是由eltrombopagag引起的
Bhargav Chandan Sumanth T1, Aditya Vijayakrishnan Nair1, Angel Miraclin T1
1Department of Neurological sciences, Christian Medical College, Vellore, Tamil Nadu, India.
Practical neurology
|March 22, 2025
概括
抗脂抗体综合征 (APS) 可以模仿免疫性血栓塞性紫外线. 对被认为是ITP的Eltrombopag治疗在患者中引发了灾难性的APS,突出了关键的诊断挑战.
科学领域:
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
- 内部医学 内部医学
背景情况:
- 抗脂抗体综合征 (APS) 可以异常呈现与孤立的血小板缺血症.
- 这种表现可能被错误地诊断为免疫血栓塞缩性紫外线 (ITP).
- 血栓形成素受体激动剂 (TPO-RAs) 用于治疗ITP.
研究的目的:
- 报告一种罕见的灾难性APS病例,该病例是由eltrombopag在被认为是ITP的患者中引发的.
- 要突出在区分APS与ITP的诊断挑战.
- 讨论如何处理这些案件.
主要方法:
- 一个32岁妇女的病例报告.
- 对临床表现,诊断和治疗过程的审查.
- 分析eltrombopag启动和灾难性的APS发展之间的时间关系.
主要成果:
- 患者最初呈现出血小板减少症,被认为是ITP.
- 用eltrombopag治疗导致灾难性APS的发展,其特点是多次缺血性心脏病发作,冠状动脉微血管血栓形成和数字.
- 停用eltrombopag和启动免疫疗法 (皮质类固醇,IVIg,rituximab) 导致临床改善,尽管有剩余的神经缺陷.
结论:
- 孤立的血小板缺血可能是APS的罕见表现特征.
- 埃尔特罗姆波帕格可能会在易受感染的个体中导致灾难性的APS.
- 及时识别和适当管理,包括取消侵权剂和免疫疗法,对于患者的结果至关重要.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
585
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
585
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
441
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
441
01:24Disorders of Hemostasis
673
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
673
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
140
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
140
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
119
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
119